Mark Burchfield Email & Phone Number

Redwood City, California, Us

Rare Disease

Paris, France, Fr

Launch of new Infusuion Therapy Tzield for patients that are positive for >2 auto immune antibodies with abnormal blood sugar. (Stage 2-Type 1)Responsible for implementing screening protocols and procedures at multiple Health Systems and Integrated Delivery Networks in the Western Pennsylvania Territory. Collaborate with Account Reimbursement team on the identification of potential patients. Create pathways for patients and family members to get insurance approval and ultimately receive the infusion treatment.

Paris, France, Fr

Diabetes Business Unit- Insulin SalesResponsibilities include launch and promotion of the biologic long acting insulin Toujeo and GlP/Insulin Fixed Ratio Combination Soliqua to endocrinologist, health care systems, hospital pharmacists, case manager, and medical directors.Responsible for development of Key Thought Leaders and providing educational support to the medical community in the Central and Western Pennsylvania territory.Promoted Avapro , Plavix, Ambien, Ambien CR, Nasacort AQ, Xyzal, and Uroxatral to various speciality providers in the field of cardiology, neurology, psychiatry, pulmonary,Allergy, and Urology.New product launches included Ambien CR, Toujeo, Soliqua, Uroxatral

Indianapolis, Indiana, Us

Promoting respiratory services and medical equipment. Responsible for managing account, promoting products, building sales at key health care accounts. Accounts included primary care physicians, pulmonary, allergy, hospitals, long term and nursing home facilities. Set up and deliver hospital in services on products and services.